Compare stocks

LIMES Schlosskliniken AG operates private clinics specializing in the treatment of stress-related illnesses, mental, and emotional disorders, including depression, affective disorders, and acute burnout conditions. The company offers services primarily to private patients, those entitled to subsidies, and self-payers. Headquartered in Cologne, Germany, LIMES Schlosskliniken has expanded its geographic footprint through acquisitions, such as a 51% stake in Liechtenstein's Clinicum Alpinum AG in 2023, and increasing its stake in Switzerland's PRC Group AG to 56% in the same year. (,) In June 2025, the company opened LIMES Schlossklinik Abtsee, a specialized clinic for young adults aged 14 to 21, located near Salzburg, Austria. This strategic expansion enhances the company's service offerings and international presence.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.